LINC02655

Across TCGA pan-cancer cohorts, LINC02655 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02655 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02655 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02655 expression acts as an unfavorable survival marker, although some lineages such as THCA show a favorable association.

ACC, LUAD, and CHOL are the cancer types where LINC02655 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.116	0.647	<.001	135	view →
LUAD	OS	Tertile	III,IV	0.068	0.680	<.001	105	view →
CHOL	OS	Tertile	II,III,IV	0.231	0.728	.004	80	view →
UCEC	OS	Tertile	All	0.873	0.934	.010	78	view →
LUSC	DFS	Tertile	II,III,IV	0.155	0.760	<.001	54	view →
READ	DFS	Tertile	All	0.082	0.845	<.001	45	view →
KIRC	OS	Tertile	All	0.450	0.674	<.001	36	view →
LIHC	DFS	Tertile	III,IV	0.094	0.424	.003	27	view →
PAAD	DFS	Tertile	All	0.275	0.490	.017	18	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
UCS	OS	Median	IV	0.240	0.616	.019	18	view →
KIRP	OS	Tertile	II,III,IV	0.587	0.885	.008	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02655–ACC (OS)

Open the ACC breakdown →